Literature DB >> 7496628

Premature Schwann cell differentiation and hypermyelination in mice expressing a targeted antagonist of the POU transcription factor SCIP.

D E Weinstein1, P G Burrola, G Lemke.   

Abstract

The transcription factor SCIP is expressed by immature neurons and Schwann cells of the developing central and peripheral nervous systems, but this expression is largely extinguished when these cells fully differentiate. In immature Schwann cells in vitro, SCIP acts as a repressor of the myelin-specific genes that mark full differentiation. We have generated transgenic mice that express a dominant-negative antagonist of SCIP, specifically targeted to developing Schwann cells. This antagonist--designated delta SCIP--is transcriptionally inactive, but retains full DNA-binding activity. Mice that express delta SCIP exhibit a debilitating peripheral neuropathy that results from developmentally advanced Schwann cell differentiation, over-expression of myelin-specific gene products, and hypermyelination. These results suggest that SCIP functions as a transcriptional sensor of differentiation cues and thereby regulates the time and place at which Schwann cells differentiate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7496628     DOI: 10.1006/mcne.1995.1018

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  17 in total

1.  Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4.

Authors:  T Ezashi; D Ghosh; R M Roberts
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  A distal upstream enhancer from the myelin basic protein gene regulates expression in myelin-forming schwann cells.

Authors:  R Forghani; L Garofalo; D R Foran; H F Farhadi; P Lepage; T J Hudson; I Tretjakoff; P Valera; A Peterson
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

3.  A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration.

Authors:  Merhnaz Ghazvini; Wim Mandemakers; Martine Jaegle; Marko Piirsoo; Siska Driegen; Manousos Koutsourakis; Xsander Smit; Frank Grosveld; Dies Meijer
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

4.  Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development.

Authors:  M Xiang; L Gan; D Li; Z Y Chen; L Zhou; B W O'Malley; W Klein; J Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 5.  Alterations in gene expression associated with primary demyelination and remyelination in the peripheral nervous system.

Authors:  A D Toews; J Hostettler; C Barrett; P Morell
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

6.  Reduced fertility in mice deficient for the POU protein sperm-1.

Authors:  R V Pearse; D W Drolet; K A Kalla; F Hooshmand; J R Bermingham; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

7.  Repression of gonadotropin-releasing hormone promoter activity by the POU homeodomain transcription factor SCIP/Oct-6/Tst-1: a regulatory mechanism of phenotype expression?

Authors:  M E Wierman; X Xiong; J K Kepa; A J Spaulding; B M Jacobsen; Z Fang; G Nilaver; S R Ojeda
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 8.  POU domain transcription factors in embryonic development.

Authors:  G J Veenstra; P C van der Vliet; O H Destrée
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

Review 9.  How Schwann Cells Sort Axons: New Concepts.

Authors:  M Laura Feltri; Yannick Poitelon; Stefano Carlo Previtali
Journal:  Neuroscientist       Date:  2015-02-16       Impact factor: 7.519

10.  Disrupted Schwann cell-axon interactions in peripheral nerves of mice with altered L1-integrin interactions.

Authors:  Kyoko Itoh; Shinji Fushiki; Hiroyuki Kamiguchi; Bernd Arnold; Peter Altevogt; Vance Lemmon
Journal:  Mol Cell Neurosci       Date:  2005-12       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.